{"database": "lobbying", "table": "lobbying_activities", "rows": [[2189320, "43fb86bc-341f-42c6-8d7f-0962de2d7590", "Q3", "DAN BURTON INTERNATIONAL LLC", 401103789, "GRANULES USA INC.", 2018, "third_quarter", "PHA", "Consultant shall pursue an effort to obtain from the United States Food and Drug Administration (FDA) expeditious processing of Client's petition to allow additional sources of API, the active ingredient in ibuprofen, to enter the American market in order to alleviate an anticipated shortage.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2018-10-17T18:36:12.610000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2189320"], "units": {}, "query_ms": 8.740445016883314, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}